Can exercising at home match gym sessions for cancer recovery?

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * ≥ 18 years and able to give informed consent * Previously diagnosed with any form of cancer and having completed systemic chemotherapy, immunotherapy or targeted therapies or local radiotherapy not more than 5 years earlier * Living within 20 km of one of the exercise locations (Lillehammer, Gjøvik, or Hamar) * Life expectancy of more than 12 months * Access to digital equipment at home (e.g. PC and/or tablet) and an email address, enabling participation on the digital exercise platform * Able to understand the Norwegian language Exclusion Criteria: * Co-morbidities prohibiting exercise according to the protocol, such as serious cardiac, pulmonary, or other organ diseases * Conditions caused by the cancer that prohibits exercise, such as recent major surgery, fractures, or pain * Still undergoing active cancer treatment * Life expectancy of less than 12 months * Reduced mental capacity such that the participant is unable to give informed consent and follow the program * Has performed regular strength training (two or more times per week) within the last three months Note on reference groups: In addition to the randomized controlled trial, the study includes two non-randomized reference groups that are allocated to the digital home-based intervention only and undergo the same test protocol as the randomized participants. These are: (i) patients undergoing active cancer treatment, and (ii) patients who have completed treatment but live more than 20 km from an exercise location. Reference-group participants must otherwise meet the same inclusion criteria regarding age, cancer diagnosis, life expectancy, digital access, and language, and are subject to the same exclusion criteria, except that ongoing active treatment and distance from an exercise location are permitted as defining features of the respective groups. Patients undergoing active cancer treatment that is expected to confer a high risk of bone marrow suppression - leading to infections, bleeding, and/or severely reduced physical capacity - are excluded.